We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Gunshot and Stabbing Victims Undergoing Fewer Surgeries

By HospiMedica International staff writers
Posted on 17 Jan 2012
An increasing number of penetrating abdominal injury (PAI) wounds are being treated using selective nonoperative management (SNOM), according to a new study.

Researchers at The Johns Hopkins School of Medicine (Baltimore, MD, USA) and Aga Khan University (Karachi, Pakistan) reviewed a total of 12,707 patients with abdominal gunshot and 13,030 patients with knife wounds identified from the US National Trauma Data Bank between 2002 and 2008. More...
Patients with PAI were categorized as those who underwent successful SNOM (no operative management required) and those who failed SNOM (surgery was required more than four hours after admission). Yearly rates of SNOM versus nontherapeutic laparotomy (NTL) were plotted, and regression analysis was performed to identify factors associated with failed SNOM and mortality.

The results showed that just over 22% of the gunshot wounds were treated using SNOM, together with just under 34% of stab wounds. The remainder of the surviving patients received NTL surgery. Failure rates fell from 33% to 20% over the study period (a reduction of 37%), most within 24 hours. The percentage of failed SNOM patients who went on to have surgery was almost the same as the percentage operated on immediately (19% versus 18% respectively). After adjusting for injury severity, demographics, and clinical variables, patients who failed SNOM were four-and-a-half times more likely to die than those successfully managed without surgery. The study was published in the January 2011 Trauma Supplement of the British Journal of Surgery (BJS).

“The results show that SNOM has a success rate of up to 80% in select patients; improved diagnostic imaging has made it easier to identify suitable patients and use of the technique has become more widespread,” said study coauthor associate professor of surgery Adil Haider, MD, codirector of the Center for Surgery, Trials and Outcomes Research at Johns Hopkins. “And they demonstrate that correctly selecting patients for nonoperative management leads to shorter hospital stays, better outcomes and reduced pressure on healthcare budgets.”

“SNOM failure, which is most common in patients with severe injuries, those needing blood transfusions and those with spleen injuries, is independently associated with increased death rates and longer hospital stays,” added Dr. Haider. “In most instances, failed SNOM was associated with increased death rates, underlining the importance of careful patient selection and protocols to reduce failure rates.”

Related Links:

Johns Hopkins School of Medicine
Aga Khan University




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.